TABLE 3.

Comparison of antibiogram data calculated by using the first patient isolate tested (M39) and patient isolates retested after 5 days (TSN)

Organism(s), method	No. of isolates tested	% Susceptible to:
		Aminoglycosides			Cephalosporins
		Amikacin	Gentamicin	Tobramycin	Cefazolin	Cefepime	Cefotaxime	Ceftazidime	Ceftriaxone	Cefuroxime
Acinetobacter spp., M39	276	96	37	78		32	28	39	18
Acinetobacter spp., TSN	305	95	34	77		28	24	35	16
Citrobacter spp., M39	363	99	89	89	43	96	83	80	82	82
Citrobacter spp., TSN	378	99	87	89	42	96	86	80	82	79
Enterobacter spp., M39	770	98	91	91	3	94	79	76	76	53
Enterobacter spp., TSN	856	98	89	90	3	94	75	74	74	52
E. coli, M39	5,123	99	94	94	88	99	98	97	99	95
E. coli, TSN	5,223	99	93	94	87	99	98	97	99	95
Klebsiella spp., M39	417	100	98	99	89	100	100	97	100	92
Klebsiella spp., TSN	1,606	99	94	94	87	98	97	96	97	92
P. mirabilis, M39	1,371	97	73	79	90	96	99	96	99	100
P. mirabilis, TSN	1,442	97	77	78	89	96	99	96	99	100
P. aeruginosa, M39	1,699	91	70	86		78		81
P. aeruginosa, TSN	2,018	88	66	83		72		77
Serratia marcescens, M39	235	99	94	84		96	86	91	92
Serratia marcescens, TSN	253	98	93	84		96	84	89	91
S. maltophilia, M39	188	24
S. maltophilia, TSN	222	24
Enterococcus spp., M39	2,057
Enterococcus spp., TSN	2,147
S. aureus, M39	3,376		90		54
S. aureus, TSN	3,677		90		53
Coagulase-negative staphylococci, M39	165		64		26
Coagulase-negative staphylococci, TSN	965		63		24
S. pneumoniae, M39	277									49
S. pneumoniae, TSN	275									49